Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6278-97-3

Post Buying Request

6278-97-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6278-97-3 Usage

General Description

H-DL-LEU-NHNH2 is a modified form of the amino acid leucine. This chemical compound consists of a dipeptide containing the amino acids D-leucine and NH2. It is commonly used in research and laboratory settings for its role in peptide synthesis and as a building block for the creation of new compounds. H-DL-LEU-NHNH2 is often utilized in the study of the structure and function of proteins and peptides, as well as in the development of pharmaceuticals and other bioactive compounds. Additionally, it is also employed in the production of peptide-based materials and in drug design and discovery.

Check Digit Verification of cas no

The CAS Registry Mumber 6278-97-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,2,7 and 8 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 6278-97:
(6*6)+(5*2)+(4*7)+(3*8)+(2*9)+(1*7)=123
123 % 10 = 3
So 6278-97-3 is a valid CAS Registry Number.

6278-97-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-amino-4-methylpentanehydrazide

1.2 Other means of identification

Product number -
Other names L-leucine hydrazide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6278-97-3 SDS

6278-97-3Relevant articles and documents

Chiral arylideneaminoimidazolidin-4-ones: Green synthesis and isomerisation mechanism in solution

Bouzayani, Nadia,Marque, Sylvain,Kacem, Yakdhane,Kra?em, Jamil,Bourdreux, Flavien,Marrot, Jér?me,Ben Hassine, Béchir

, p. 4777 - 4786 (2019/03/26)

A green and eco-friendly synthetic approach of pure 2,5-disubstituted 3-arylideneaminoimidazolidin-4-ones is developed using water as the solvent. These new chiral arylideneaminoimidazolidin-4-one derivatives were obtained diastereoselectively in high ove

Structure-based design of inhibitors of the aspartic protease endothiapepsin by exploiting dynamic combinatorial chemistry

Mondal, Milon,Radeva, Nedyalka,Koester, Helene,Park, Ahyoung,Potamitis, Constantinos,Zervou, Maria,Klebe, Gerhard,Hirsch, Anna K. H.

supporting information, p. 3259 - 3263 (2014/04/03)

Structure-based design (SBD) can be used for the design and/or optimization of new inhibitors for a biological target. Whereas de novo SBD is rarely used, most reports on SBD are dealing with the optimization of an initial hit. Dynamic combinatorial chemistry (DCC) has emerged as a powerful strategy to identify bioactive ligands given that it enables the target to direct the synthesis of its strongest binder. We have designed a library of potential inhibitors (acylhydrazones) generated from five aldehydes and five hydrazides and used DCC to identify the best binder(s). After addition of the aspartic protease endothiapepsin, we characterized the protein-bound library member(s) by saturation-transfer difference NMR spectroscopy. Cocrystallization experiments validated the predicted binding mode of the two most potent inhibitors, thus demonstrating that the combination of de novo SBD and DCC constitutes an efficient starting point for hit identification and optimization. The dynamic duo: The combination of de novo structure-based design and dynamic combinatorial chemistry has been applied to the identification of novel acylhydrazone-based inhibitors for the aspartic protease endothiapepsin. 1H-STD-NMR spectroscopy has been used to identify the binders from the dynamic combinatorial libraries. Proposed binding modes of the most potent inhibitors have been confirmed by X-ray crystallography.

Synthesis and Antitubercular Activity of Novel Amino Acid Derivatives

Da Costa, Cristiane F.,Pinheiro, Alessandra C.,De Almeida, Mauro V.,Lourenco, Maria C.S.,De Souza, Marcus V.N.

, p. 216 - 222 (2012/04/23)

In this work, 17 new N-acylhydrazone derivatives of amino acids have been evaluated for their in vitro antibacterial activity against Mycobacterium tuberculosis H37Rv. The compounds 8b, 8e, 8f, 9a-d, and 10c exhibited an important minimum inhibitory concentration activity between 12.5 and 50μg/mL, which can be compared with that of the tuberculostatic drug d-cycloserine (20μg/mL). In this work 17 new N-acylhydrazone derivatives of amino acids have been evaluated for their in vitro antibacterial activity against Mycobacterium tuberculosis H37Rv. Eight compounds were non-cytotoxic and exhibited an important MIC activity between 12.5 and 50μg/mL, which can be compared with that of the tuberculostatic drug d-cycloserine (20μg/mL).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6278-97-3